Benitec Biopharma Inc. Successfully Closes $18 Million Public Offering: A Milestone for Growth and Innovation
The Exciting News from Benitec Biopharma Inc. By: Anonymous On September 16, 2022, Benitec Biopharma Inc. made a groundbreaking announcement. The development-stage biotechnology company, known for its innovative gene therapy-focused approach, revealed that it recently closed a successful underwritten public offering. This offering included nearly 30 million shares of its common stock, resulting in a…